HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR’s Silica/Silicates Review Could Be First Test Of Panel’s Revised Inhalation Assessment Approach

Executive Summary

The Cosmetic Ingredient Review Expert Panel has been grappling with the question of just how vital particle-size data is to assessing the potential inhalation risks of ingredients used in cosmetic sprays and powders. Its pending review of silica/silicate ingredients could provide a look at the panel’s evolving approach in action, with particle size data for all ingredients requested from industry ASAP.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel